2011Medical Journal of Chinese People's HealthRequires access

Comparative study of Mirtazapine and Fluoxetine in the treatment of depression

Zhou Chang-feng

Open publisher page 0 citations

Abstract

Objective:To explore the efficacy and safety of Mirtazapine and Fluoxetine in the treatment of depression.Methods:70 patients with depression were randomly devided into two groups,with Mirtazapine or Fluoxetine for 8 weeks.HAMD scale and Tess scale were used to evaluate efficacy and side effects respectively before and at ends of 1,2,4,8 weeks of treatment.Results:Compare two groups′ HAMD scores before treatment and after treatment of 1,2,4,8 weeks.At the 1st weekend,the reduction of mirtazapine group was greater than fluoxetine group.There was significant different(P0.05).At the 2nd weekend,the reduction rate of fluoxetine group was greater than mirtazapine group.There was significant different(P 0.05).After treatment of 4,8 weeks,there was no statistical different in efficacy(P0.05).Two groups showed no significant difference in adverse reactions.Conclusion:In the treatment of depression,Mirtazapine and Fluoxetine are similar in efficacy.Mirtazapine is quicker in efficacy beginning and it can be used in clinical practice.

About this research paper

What this paper is about

Objective:To explore the efficacy and safety of Mirtazapine and Fluoxetine in the treatment of depression.Methods:70 patients with depression were randomly devided into two groups,with Mirtazapine or Fluoxetine for 8 weeks.HAMD scale and Tess scale were used to evaluate efficacy and side effects respectively before and at ends of 1,2,4,8 weeks of treatment.Results:Compare two groups′ HAMD scores before treatment and after treatment of 1,2,4,8 weeks.At the 1st weekend,the reduction of mirtazapine group was greater than fluoxetine group.There was significant different(P0.05).At the 2nd weekend,the reduction rate of fluoxetine group was greater than mirtazapine group.There was significant different(P 0.05).After treatment of 4,8 weeks,there was no statistical different in efficacy(P0.05).Two groups showed no significant difference in adverse reactions.Conclusion:In the treatment of depression,Mirtazapine and Fluoxetine are similar in efficacy.Mirtazapine is quicker in efficacy beginning and it can be used in clinical practice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the efficacy and safety of Mirtazapine and Fluoxetine in the treatment of depression.Methods:70 patients with depression were randomly devided into two groups,with Mirtazapine or Fluoxetine for 8 weeks.HAMD scale and Tess scale were used to evaluate efficacy and side effects respectively before and at ends of 1,2,4,8 weeks of treatment.Results:Compare two groups′ HAMD scores before treatment and after treatment of 1,2,4,8 weeks.At the 1st weekend,the reduction of mirtazapine group was greater than fluoxetine group.There was significant different(P0.05).At the 2nd weekend,the reduction rate of fluoxetine group was greater than mirtazapine group.There was significant different(P 0.05).After treatment of 4,8 weeks,there was no statistical different in efficacy(P0.05).Two groups showed no significant difference in adverse reactions.Conclusion:In the treatment of depression,Mirtazapine and Fluoxetine are similar in efficacy.Mirtazapine is quicker in efficacy beginning and it can be used in clinical practice.

Key concepts: Mirtazapine, Hamd, Fluoxetine, Hamilton depression scale, Depression (economics), Significant difference, Adverse effect, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative study of Mirtazapine and Fluoxetine in the treatment of depression — Research Paper | ScholarLens